Tris Pharma, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 101
Rang # Quantité totale PI 12 911
Note d'activité PI 2,6/5.0    58
Rang # Activité PI 12 455
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

61 15
4 3
14 0
4
 
Dernier brevet 2025 - Methods for improving driving be...
Premier brevet 1999 - Pharmaceutical composition compr...
Dernière marque 2025 - ADNEURIS THERAPEUTICS
Première marque 2000 - TRIS PHARMA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Distributorship of pain relief medications; distributorship of pharmaceutical medicines and prepa...
2024 P/S PHARMACEUTICAL PREPARATIONS WHICH ACT ON THE CENTRAL NERVOUS SYSTEM, INCLUDING MODIFIED RELEASE A...
P/S Pharmaceutical preparations which act on the central nervous system, including modified release a...
P/S Pharmaceutical or medical preparations in liquid dosage form, including, drug delivery systems co...
Invention Methods for improving driving behavior. Use of an oral amphetamine extended release solid dose f...
Invention Low sodium oxybate once nightly composition. Compositions providing a once-a-night dose of oxybat...
Invention Liquid clonidine extended release composition. An oral clonidine dosage unit providing a twenty-...
2023 Invention Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming sy...
Invention Methylphenidate extended release chewable tablet. An oral methylphenidate extended release table...
Invention Extended release amphetamine tablets. An oral amphetamine extended release solid dose is describe...
Invention Extended release amphetamine compositions. An oral amphetamine extended release liquid suspensio...
2022 Invention Novel clonidine formulation. An oral clonidine dosage unit providing a twenty-four hour extended...
Invention Oxybate polyethylene glycol prodrugs. Oxybate-PEG ester prodrugs are provided herein in which th...
Invention Oxybate polyethylene glycol prodrugs. Oxybate-PEG ester prodrugs are provided herein in which the...
Invention Oxybate - cyclodextrin products and conjugates. Oxybate cyclodextrin mono-esters, di-esters, and ...
Invention Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pu...
Invention Modified release drug powder composition comprising gastro-retentive raft forming systems having ...
Invention Modified release formulations containing drug-ion exchange resin complexes. A particulate, modif...
Invention Benzonatate modified release solid tablets and capsules. A modified release benzonatate solid tab...
2021 Invention Benzonatate modified release solid tablets and capsules. A 12-hour anti-tussive modified release ...
Invention Liquid clonidine extended release composition. An oral clonidine dosage unit providing a twenty-f...
Invention Methylphenidate extended release chewable tablet. An oral methylphenidate extended release tablet...
P/S Pharmaceutical preparations.
Invention Modified release formulations containing drug-ion exchange resin complexes. An aqueous liquid su...
2020 P/S Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inh...
2019 Invention Modified release formulations containing drug-ion exchange resin complexes. An aqueous liquid sus...
P/S Pharmaceutical preparations which act on the central nervous system, namely modified release and ...
P/S Pharmaceutical preparations, namely, pharmaceutical preparations containing the drug clonidine, i...
Invention Extended release amphetamine compositions. An oral amphetamine extended release liquid suspension...
2018 Invention Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system...
2017 Invention Benzonatate modified release solid tablets and capsules. A modified release benzonatate solid ta...
Invention Modified release formulations containing drug-ion exchange resin complexes. A particulate, modifi...
2016 Invention Orally effective methylphenidate extended release powder and aqueous suspension product. An oral...
2015 P/S Pharmaceutical preparations for treating coughs, colds, allergies and respiratory diseases, and s...
P/S Oral modified release, extended release, and/or sustained release pharmaceutical preparations for...
2013 P/S Pharmaceutical preparations for treating coughs, colds, allergies, and respiratory diseases, and ...
2008 P/S Pharmaceutical or medical preparations in liquid dosage form, namely, drug delivery systems compr...
2004 P/S Scientific research program for the development of preparations or products in liquid form that d...
2000 P/S Scientific research and development for pharmaceuticals, neutraceuticals, drug delivery products ...